NIKI
Niki BioSolutions, Inc.
There isn't enough reported data to score NIKI yet.
NIKI Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
NIKI's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
NIKI PE Valuation
NIKI has no meaningful PE right now: it lost money over the past year.
NIKI Forward outlook
There aren't enough analyst estimates for NIKI to show an outlook.
NIKI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2025 | -$23.70 | -152% |
| Q2 2023 | -$36.80 | -$7.80 |
| Q4 2022 | -$27.50 | +$43.50 |
| Q2 2022 | -$29.00 | -$23.00 |
| Q4 2021 | -$71.00 | -455% |
NIKI is still losing money, but far less than before: $23.70 per share over the past year, against $71.00 at its worst in late 2021.
NIKI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2019 | $295.4K | -23% |
| Q2 2019 | $239.8K | +799% |
NIKI's revenue has slid since its 2018 peak: $0 last quarter, down 100% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2019 | -3382% | N/A |
| Q2 2019 | -3423% | N/A |
| Q4 2018 | -2693% | N/A |
| Q2 2018 | -18286% | N/A |
NIKI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2024 | $89.7K | +$1.6M |
| Q4 2023 | -$1.5M | +$3.9M |
| Q2 2023 | -$6.2M | +$867.8K |
| Q4 2022 | -$5.4M | +$2.6M |
| Q2 2022 | -$7.1M | -$304.5K |
| Q4 2021 | -$8M | +$989.7K |
| Q2 2021 | -$6.8M | +$320.2K |
| Q4 2020 | -$9M | -101% |
NIKI has burned cash in most quarters: −$13M over the past year, against −$31M the year before.
NIKI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -90% | -640K shares |
| 1 year | +40% | +20.6K shares |
| 3 years | +149% | +43.4K shares |
NIKI has 72,393 diluted shares, down 86% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2024 | — |
| Q4 2023 | — |
| Q4 2019 | — |
| Q4 2018 | $11.1M |
| Q2 2018 | — |
NIKI Net Leverage
NIKI's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
NIKI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.1 | Neutral |
| Stochastic | 2.0 | Oversold |
NIKI's weekly RSI is 58 (neutral) and its Stochastic is 2 (oversold).
NIKI PE vs Healthcare Sector
NIKI has no meaningful PE right now: it lost money over the past year.
NIKI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.78 | 39% below |
NIKI is in a downtrend: it's below all one of its weekly moving averages, and 39% below its 8-week average.
NIKI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2026 YTD | $7.00 | $1.70 | -76% |
It's down 76% so far in 2026.